Dive Medicine

Hydrogen Sulphide Poisoning and Hyperbaric Oxygen

6 min read · 1 March 2026
Hero illustration for the article “Hydrogen Sulphide Poisoning and Hyperbaric Oxygen”
2,958 reads

Severe hydrogen sulphide poisoning treated with 4-dimethylaminophenol and hyperbaric oxygen is a 2010 publication by Lindenmann and colleagues in Diving and Hyperbaric Medicine. Its subject is the medical response to severe hydrogen sulphide exposure, including an antidote and hyperbaric oxygen—an urgent topic wherever people work or dive around contaminated water, confined spaces or industrial sources.

Why is hydrogen sulphide dangerous?

Hydrogen sulphide is a toxic gas that can be present in environments where organic material decomposes and in some industrial settings. Exposure can occur by inhalation; in underwater and confined-space work, the danger is compounded by the difficulty of escaping quickly and providing immediate care.

At a cellular level, hydrogen sulphide can disrupt the use of oxygen by tissues. This means that serious poisoning is not simply a matter of how much oxygen is available in the surrounding air or blood: the body’s ability to use oxygen for essential cellular processes may also be impaired. Severe exposure can rapidly become life-threatening.

The gas also creates hazards for rescuers. A person attempting an unprotected rescue may enter the same toxic atmosphere, turning one casualty into several. Safe access, removal from exposure and emergency medical assessment are therefore central concerns in any response.

What do 4-dimethylaminophenol and hyperbaric oxygen represent?

4-dimethylaminophenol is a chemical antidote used in the treatment of certain forms of poisoning. In hydrogen sulphide poisoning, antidote treatment is considered in the context of a toxin that interferes with cellular oxygen use. The title places this therapy alongside hyperbaric oxygen, indicating a subject at the intersection of toxicology and pressure-based medicine.

Hyperbaric oxygen treatment involves breathing oxygen at a pressure higher than that at the surface, within a specialised chamber. The increased pressure raises the amount of oxygen dissolved in blood plasma. Its role in a poisoning case must be considered alongside immediate resuscitation and other supportive care; it is not a substitute for removing the person from exposure or stabilising critical functions.

  • Toxic exposure: recognising the source and ending further contact safely.
  • Cellular oxygen use: distinguishing oxygen delivery from the tissues’ ability to use it.
  • Antidote therapy: weighing a targeted drug intervention in a time-critical emergency.
  • Hyperbaric treatment: considering oxygen under pressure as part of specialist care.
  • Rescue safety: protecting responders from entering a contaminated environment without appropriate precautions.

Why is this relevant to diving medicine?

Diving medicine deals not only with pressure-related illness, but also with emergencies that may occur during underwater work, in support facilities or around contaminated aquatic environments. Toxic gas exposure is a different problem from decompression illness, yet both can require rapid recognition, careful oxygen management and access to specialised medical expertise.

For diving physicians and hyperbaric clinicians, poisoning cases raise important questions about treatment priorities and the suitability of chamber care. A patient may need urgent stabilisation before transport or exposure to increased pressure. The clinical team must consider the person’s condition, the risks of treatment and the resources available.

Scientific divers and occupational teams can also use this subject to strengthen hazard planning. Identifying possible sources, establishing safe rescue procedures and ensuring that emergency arrangements account for toxic exposure are practical parts of risk management. Prevention matters because rescue in a contaminated atmosphere can be exceptionally hazardous.

How does this topic fit into hyperbaric research?

Hyperbaric medicine has long examined how oxygen behaves under pressure and when that environment may have a therapeutic role. Poisoning is one area where researchers and clinicians consider whether altered oxygen delivery could help, while also accounting for the specific mechanism of the toxin and the patient’s immediate needs.

Work on severe poisoning treated with both an antidote and hyperbaric oxygen sits within a broader clinical challenge: assessing therapies used together in uncommon, rapidly evolving emergencies. Such cases invite attention to timing, treatment sequence, physiological rationale and the practical demands of specialist care. They also connect diving medicine with emergency medicine, toxicology and occupational health.

The publication by Lindenmann and colleagues belongs to this discussion through its stated focus on severe hydrogen sulphide poisoning, 4-dimethylaminophenol and hyperbaric oxygen. For readers, the key value of the subject is understanding why toxicology and hyperbaric care may intersect—and why decisions in such cases require experienced clinical judgment.

Frequently asked questions

What is hydrogen sulphide poisoning?
It is illness caused by exposure to hydrogen sulphide, a toxic gas that can interfere with cellular oxygen use. Severe exposure is a medical emergency.
What does hyperbaric oxygen therapy involve?
It involves breathing oxygen at increased pressure in a specialised chamber. Its possible role depends on the condition being treated and requires specialist assessment.
Is this publication relevant to divers?
Yes. It addresses toxic exposure and specialist treatment—issues relevant to diving, underwater work and hyperbaric practice. Anyone facing a real exposure requires emergency medical care; treatment decisions should involve qualified clinicians.

Citation details

  • Title: Severe hydrogen sulphide poisoning treated with 4-dimethylaminophenol and hyperbaric oxygen
  • Authors: Lindenmann, J; Matzi, V; Neuboeck, N; Ratzenhofer-Komenda, B; Maier, A; Smolle-Juettner, FM
  • Year: 2010
  • Published in: Diving and Hyperbaric Medicine 2010 Dec;40(4):213-7
  • Identifiers: 1833-3516, PMID 23111938
  • Repository record: Rubicon Research Repository, handle 123456789/10235

This page is an original summary written by the Rubicon editors from the publication’s bibliographic record. It does not reproduce the paper, its abstract or its data; consult the publication itself for its methods and findings.

Related reading on Rubicon

Written byImogen Faraday

Imogen Faraday explores the broader science of diving, including underwater physiology and environmental interactions. Her editorial style combines rigorous scientific review with engaging storytelling to foster a deeper understanding of diving science among enthusiasts and researchers. She values interdisciplinary perspectives and innovation in dive technology.